Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
PLOS Global Public Health|May 20, 2025
Comparing and integrating human mobility data sources for measles transmission modeling in ZambiaNatalya Kostandova, Christine Prosperi, Simon Mutembo, et al.
Epidemiology and Infection|December 6, 2024
Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 - 2019Christine Prosperi, Alvira Z Hasan, Amy K Winter, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2024
Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance SummitAndrea C Carcelen, Alex C Kong, Saki Takahashi, et al.
Epidemiology and Infection|November 18, 2024
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in IndiaChristine Prosperi, Alvira Z Hasan, Amy K Winter, et al.
Lancet Regional Health. Americas|March 27, 2026
Modernizing public health surveillance for global health security leveraging AIKehinde O Ogunyemi, Affan T Shaikh, Adnan Bashir, et al.
Plos One|March 29, 2024
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020Jeromie Wesley Vivian Thangaraj, Christine Prosperi, Muthusamy Santhosh Kumar, et al.
Vaccine|December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20C Prosperi, J W V Thangaraj, A Z Hasan, et al.
The Lancet. Global Health|March 14, 2024
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling studyAnna-Maria Hartner, Xiang Li, Susy Echeverria-Londono, et al.
Lancet (London, England)|May 14, 2026
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling studyKaty A M Gaythorpe, Xiang Li, Manjari Shankar, et al.
Vaccine|July 3, 2024
Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022Devika Shanmugasundaram, Rajlakshmi Viswanathan, Amy K Winter, et al.
Pageof 29